The scope and sequence of growth factor delivery for vascularized bone tissue regeneration

被引:62
作者
Bayer, E. A. [1 ,6 ]
Gottardi, R. [2 ,3 ,6 ,7 ]
Fedorchak, M. V. [1 ,2 ,4 ,6 ]
Little, S. R. [1 ,2 ,5 ,6 ]
机构
[1] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA
[5] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA
[6] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA
[7] RiMED Fdn, Palermo, Italy
基金
美国国家卫生研究院;
关键词
Growth factors; Bone regeneration; Controlled release; Biomaterials; Tissue engineering; PLATELET-RICH PLASMA; SHELL DESIGNED SCAFFOLDS; CALCIUM-PHOSPHATE CEMENT; IN-VIVO; MORPHOGENETIC PROTEIN-2; CONTROLLED-RELEASE; ANIMAL-MODELS; FACTOR-BB; DRUG-DELIVERY; DUAL DELIVERY;
D O I
10.1016/j.jconrel.2015.08.004
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Bone regeneration is a complex process, that in vivo, requires the highly coordinated presentation of biochemical cues to promote the various stages of angiogenesis and osteogenesis. Taking inspiration from the natural healing process, a wide variety of growth factors are currently being released within next generation tissue engineered scaffolds (in a variety of ways) in order to heal non-union fractures and bone defects. This review will focus on the delivery of multiple growth factors to the bone regeneration niche, specifically 1) dual growth factor delivery signaling and crosstalk, 2) the importance of growth factor timing and temporal separation, and 3) the engineering of delivery systems that allow for temporal control over presentation of soluble growth factors. Alternative methods for growth factor presentation, including the use of gene therapy and platelet-rich plasma scaffolds, are also discussed. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:129 / 140
页数:12
相关论文
共 135 条
[1]
Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
[2]
ANDREW JG, 1995, BONE, V16, P455
[3]
[Anonymous], 2009, AAOS NOW
[4]
Platelet-Rich Plasma: A Literature Review [J].
Arora, Navneet S. ;
Ramanayake, Thaminda ;
Ren, Yan-Fang ;
Romanos, Georgios E. .
IMPLANT DENTISTRY, 2009, 18 (04) :303-310
[5]
Sequential growth factor delivery from complexed microspheres for bone tissue engineering [J].
Basmanav, F. Buket ;
Kose, Game T. ;
Hasirci, Vasif .
BIOMATERIALS, 2008, 29 (31) :4195-4204
[6]
Endocultivation: the influence of delayed vs. simultaneous application of BMP-2 onto individually formed hydroxyapatite matrices for heterotopic bone induction [J].
Becker, S. T. ;
Bolte, H. ;
Schuenemann, K. ;
Seitz, H. ;
Bara, J. J. ;
Beck-Broichsitter, B. E. ;
Russo, P. A. J. ;
Wiltfang, J. ;
Warnke, P. H. .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2012, 41 (09) :1153-1160
[7]
Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects [J].
Betz, O. B. ;
Betz, V. M. ;
Nazarian, A. ;
Egermann, M. ;
Gerstenfeld, L. C. ;
Einhorn, T. A. ;
Vrahas, M. S. ;
Bouxsein, M. L. ;
Evans, C. H. .
GENE THERAPY, 2007, 14 (13) :1039-1044
[8]
Transforming growth factor-beta 1 incorporation in a calcium phosphate bone cement: Material properties and release characteristics [J].
Blom, EJ ;
Klein-Nulend, J ;
Wolk, JGC ;
van Waas, MAJ ;
Driessens, FCM ;
Burger, EH .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 59 (02) :265-272
[9]
Biomimetic gelatin-octacalcium phosphate core-shell microspheres [J].
Boanini, Elisa ;
Bigi, Adriana .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2011, 362 (02) :594-599
[10]
Effects of protein dose and delivery system on BMP-mediated bone regeneration [J].
Boerckel, Joel D. ;
Kolambkar, Yash M. ;
Dupont, Kenneth M. ;
Uhrig, Brent A. ;
Phelps, Edward A. ;
Stevens, Hazel Y. ;
Garcia, Andres J. ;
Guldberg, Robert E. .
BIOMATERIALS, 2011, 32 (22) :5241-5251